ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1
Trial details
- Registry ID
- NCT05507203
- Phase
- Phase 3
Drug identity checked against registry records
Also recorded as Obefazimod
| No regulatory events match this view.This does not mean no FDA events have occurred. |